NIH-funded research R15 grant

Investigating the effects of cobalt-based nanomaterials on lung health using a 3D lung model

Official title: A meta-transcriptomic assessment of chronic respiratory exposure to cobalt-based nanomaterials using a microfluidic three-dimensional lung model for determining potential predisposition to lung injury

Funded at Tarleton State University · NIH-10974562 · Data updated 2026-11-12

This study is looking at how tiny cobalt-based materials, which are used in many products, might affect lung health when breathed in, and it's designed for anyone interested in understanding the potential long-term effects on lung cells, like those involved in breathing and immune responses.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionTarleton State University
NIH-funded
Lab location1 site (Stephenville, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2027
Funding year2024
Award (this year)$370,980
NIH project number1R15ES036711-01
Project IDNIH-10974562 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been exposed to cobalt-based nanomaterials, particularly those in occupational settings or environments where these materials are prevalent.

Less likely to help

Patients who have no history of exposure to cobalt-based nanomaterials or related respiratory conditions may not benefit from this research.

What this research studies

This research explores how cobalt-based nanomaterials, which are increasingly used in various applications, may affect lung health when inhaled. Using a microfluidic three-dimensional lung model, the study aims to simulate chronic exposure to these materials and assess their impact on lung cells, including respiratory epithelial and immune cells. The researchers will analyze how these nanomaterials interact with lung cells over several weeks, focusing on potential long-term effects such as fibrosis. By employing advanced techniques like RNA sequencing, the study seeks to provide insights into the toxicological effects of these materials.

Why it matters

Potential benefit: If successful, this research could lead to a better understanding of the risks associated with cobalt-based nanomaterials and inform safety regulations to protect lung health.

How similar studies have gone: While the use of nanomaterials in research is growing, this specific approach using a 3D lung model to assess chronic exposure effects is relatively novel and has not been extensively tested.

Where this research is happening

  • Tarleton State University
    Stephenville, United States
    Active

Researchers

  • Principal investigator: Speshock, Janice — Tarleton State University
  • Study coordinator: Speshock, Janice

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.